MentalHealthDaily

MIND Migraine Study Completed 3,688 Smartphone Cognition Assessments

by GLOOM

MHD featured image for the MIND migraine smartphone cognition feasibility cohort.

The MIND migraine feasibility study showed that remote migraine-cognition monitoring can produce a large daily dataset: 177 baseline participants completed 3,688 smartphone assessments, covering 70.8% of possible study days.1 The finding supports digital migraine endpoint infrastructure while leaving treatment effects and diagnostic thresholds untested. Research Highlights Daily monitoring was feasible: Participants completed 3,688 daily smartphone …

Anti-CGRP Monoclonal Antibodies to Prevent Chronic Migraine (2023 Review)

by GLOOM

Migraine, a primary headache disorder, significantly impacts the quality of life of millions worldwide. In recent years, the focus has shifted toward developing targeted therapies, particularly monoclonal antibodies (mAbs) against the calcitonin-gene-related peptide (CGRP), to prevent chronic migraine attacks. A relatively recent comprehensive network meta-analysis (NMA) evaluated the efficacy and safety of various anti-CGRP mAbs, …

Botox For Migraines: Facial Injections To Prevent Headaches?

by GLOOM

Botox (onabotulinumtoxinA) is a purified toxin derived from fermentation of the anaerobic bacterium Clostridium botulinum type A. Most people are familiar with the cosmetic application of Botox whereby it is injected into facial muscles with the intent of reducing wrinkles, enhancing skin smoothness, and improving facial aesthetics. However, in addition to its cosmetic use, Botox …